U01 CA261277/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2021	21
2022	14
2023	7
2024	4

1

Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics.

Ma KC, Menkir TF, Kissler S, Grad YH, Lipsitch M. Ma KC, et al. Elife. 2021 May 18;10:e66601. doi: 10.7554/eLife.66601. Elife. 2021. PMID: 34003112 Free PMC article.

2

Fairness and efficiency considerations in COVID-19 vaccine allocation strategies: A case study comparing front-line workers and 65-74 year olds in the United States.

Rumpler E, Feldman JM, Bassett MT, Lipsitch M. Rumpler E, et al. PLOS Glob Public Health. 2023 Feb 6;3(2):e0001378. doi: 10.1371/journal.pgph.0001378. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 36962865 Free PMC article.

3

SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact.

Lipsitch M, Krammer F, Regev-Yochay G, Lustig Y, Balicer RD. Lipsitch M, et al. Nat Rev Immunol. 2022 Jan;22(1):57-65. doi: 10.1038/s41577-021-00662-4. Epub 2021 Dec 7. Nat Rev Immunol. 2022. PMID: 34876702 Free PMC article. Review.

4

Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load.

Kennedy-Shaffer L, Kahn R, Lipsitch M. Kennedy-Shaffer L, et al. Epidemiology. 2021 Nov 1;32(6):820-828. doi: 10.1097/EDE.0000000000001415. Epidemiology. 2021. PMID: 34469363 Free PMC article.

5

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.

Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin EG, Rubin C, Indenbaum V, Tal I, Zavitan M, Zuckerman N, Bar-Chaim A, Kreiss Y, Regev-Yochay G. Bergwerk M, et al. N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28. N Engl J Med. 2021. PMID: 34320281 Free PMC article.

6

How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.

Accorsi EK, Qiu X, Rumpler E, Kennedy-Shaffer L, Kahn R, Joshi K, Goldstein E, Stensrud MJ, Niehus R, Cevik M, Lipsitch M. Accorsi EK, et al. Eur J Epidemiol. 2021 Feb;36(2):179-196. doi: 10.1007/s10654-021-00727-7. Epub 2021 Feb 25. Eur J Epidemiol. 2021. PMID: 33634345 Free PMC article. Review.

7

Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimates.

Brown TS, de Salazar Munoz PM, Bhatia A, Bunda B, Williams EK, Bor D, Miller JS, Mohareb AM, Thierauf J, Yang W, Villalba J, Naranbai V, Beltran WG, Miller TE, Kress D, Stelljes K, Johnson K, Larremore DB, Lennerz J, Iafrate AJ, Balsari S, Buckee CO, Grad YH. Brown TS, et al. medRxiv [Preprint]. 2021 Oct 5:2021.02.03.21251011. doi: 10.1101/2021.02.03.21251011. medRxiv. 2021. PMID: 33564784 Free PMC article. Preprint.

8

Interpreting vaccine efficacy trial results for infection and transmission.

Lipsitch M, Kahn R. Lipsitch M, et al. Vaccine. 2021 Jul 5;39(30):4082-4088. doi: 10.1016/j.vaccine.2021.06.011. Epub 2021 Jun 12. Vaccine. 2021. PMID: 34130883 Free PMC article.

9

On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community.

Goldstein E, Lipsitch M, Cevik M. Goldstein E, et al. J Infect Dis. 2021 Feb 13;223(3):362-369. doi: 10.1093/infdis/jiaa691. J Infect Dis. 2021. PMID: 33119738 Free PMC article. Review.

10

Optimizing prevalence estimates for a novel pathogen by reducing uncertainty in test characteristics.

Larremore DB, Fosdick BK, Zhang S, Grad YH. Larremore DB, et al. Epidemics. 2022 Dec;41:100634. doi: 10.1016/j.epidem.2022.100634. Epub 2022 Sep 27. Epidemics. 2022. PMID: 36191537 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year